SWOG clinical trial number
E1395

A Randomized Phase III Evaluation of Paclitaxel + Cisplatin Versus Cisplatin + 5-FU in Advanced Head and Neck Cancer

Closed
Phase
Published
Abbreviated Title
A Randomized Phase III Evaluation of Paclitaxel + Cisplatin Versus Cisplatin + 5-FU in Advanced Head and Neck Cancer
Activated
04/01/1999
Closed
01/12/2000

Publication Information Expand/Collapse

2005

Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an Intergroup trial of the Eastern Cooperative Oncology Group

MK Gibson;Y Li;B Murphy;MHA Hussain;RC DeConti;J Ensley;AA Forastiere Journal of Clinical Oncology 23(15):3562-3567

2002

Quality of life and pain assessment for head and neck cancer patients treated on E1395: a comparison of two different cisplatin-based chemotherapy regimens.

N Wells;B Murphy;M Dietrich;A Forastiere;Y Li;D Cella Proc of the American Society of Clinical Oncology 21:227a(#907)

2001

Phase III study comparing cisplatin (C) & 5-flurouracil (F) versus cisplatin (C) & paclitaxel (T) in metastatic/recurrent head & neck cancer (MHNC).

B Murphy;Y Li;D Cella;A Karnad;M Hussain;A Forastiere Proc of the American Society of Clinical Oncology 20:224a(#894)